RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maria Figueiredo-Pereira to Ubiquitins

This is a "connection" page, showing publications Maria Figueiredo-Pereira has written about Ubiquitins.
Connection Strength

1.092
  1. Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys. 2000 Feb 15; 374(2):325-33.
    View in: PubMed
    Score: 0.179
  2. Figueiredo-Pereira ME, Cohen G. The ubiquitin/proteasome pathway: friend or foe in zinc-, cadmium-, and H2O2-induced neuronal oxidative stress. Mol Biol Rep. 1999 Apr; 26(1-2):65-9.
    View in: PubMed
    Score: 0.168
  3. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998 Dec; 21(12):516-20.
    View in: PubMed
    Score: 0.164
  4. Figueiredo-Pereira ME, Yakushin S, Cohen G. Accumulation of ubiquitinated proteins in mouse neuronal cells induced by oxidative stress. Mol Biol Rep. 1997 Mar; 24(1-2):35-8.
    View in: PubMed
    Score: 0.145
  5. Figueiredo-Pereira ME, Berg KA, Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J Neurochem. 1994 Oct; 63(4):1578-81.
    View in: PubMed
    Score: 0.123
  6. Arnaud L, Robakis NK, Figueiredo-Pereira ME. It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener Dis. 2006; 3(6):313-9.
    View in: PubMed
    Score: 0.070
  7. Oliveros G, Wallace CH, Chaudry O, Liu Q, Qiu Y, Xie L, Rockwell P, Figueiredo-Pereira ME, Serrano PA. Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. Brain. 2023 03 01; 146(3):898-911.
    View in: PubMed
    Score: 0.055
  8. Korsmeyer KK, Davoll S, Figueiredo-Pereira ME, Correia MA. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome? Arch Biochem Biophys. 1999 May 01; 365(1):31-44.
    View in: PubMed
    Score: 0.042
  9. Figueiredo-Pereira ME, Yakushin S, Cohen G. Disruption of the intracellular sulfhydryl homeostasis by cadmium-induced oxidative stress leads to protein thiolation and ubiquitination in neuronal cells. J Biol Chem. 1998 May 22; 273(21):12703-9.
    View in: PubMed
    Score: 0.040
  10. Figueiredo-Pereira ME, Chen WE, Li J, Johdo O. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome. J Biol Chem. 1996 Jul 12; 271(28):16455-9.
    View in: PubMed
    Score: 0.035
  11. Gregori L, Fuchs C, Figueiredo-Pereira ME, Van Nostrand WE, Goldgaber D. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem. 1995 Aug 25; 270(34):19702-8.
    View in: PubMed
    Score: 0.033
  12. Wilk S, Figueiredo-Pereira ME. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Enzyme Protein. 1993; 47(4-6):306-13.
    View in: PubMed
    Score: 0.027
  13. Wang HF, Figueiredo Pereira ME, Correia MA. Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes. Arch Biochem Biophys. 1999 May 01; 365(1):45-53.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support